Bioidentical vs FDA-Approved HRT: Sorting the Terms
SaveBioidentical does not automatically mean safer. Many FDA-approved hormones, such as estradiol and micronized progesterone, are already bioidentical. The real gap is oversight: custom-compounded preparations skip FDA testing for dose and safety, and major menopause societies do not consider them safer. Regulated body-identical options exist for most people.
Last updated: July 2026
What does 'bioidentical' actually mean?
Bioidentical hormones share the exact molecular structure of the hormones a woman's own ovaries make, such as estradiol and progesterone 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. The word describes chemistry, not a source or a safety grade; a bioidentical molecule can be manufactured in a regulated factory or mixed in a compounding pharmacy 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause..
Marketing that expanded in the 1990s and 2000s often implies bioidentical means natural and therefore gentler, but plant-derived starting materials are chemically processed in both cases 2Ref 2American College of Obstetricians and Gynecologists (2014).ACOG Practice Bulletin No. 141: management of menopausal symptoms.ACOG guidance that compounded bioidentical preparations are not recommended over FDA-approved therapy and can carry the same class risks without standardized oversight.. According to the Menopause Society, the term on its own tells you nothing about whether a product has been tested 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. What matters far more is how the specific product is regulated and dosed.
Are FDA-approved bioidentical hormones already available?
Several FDA-approved products are themselves bioidentical, so patients do not have to choose between natural and regulated. These include transdermal 17-beta estradiol patches and gels and oral micronized progesterone, all of which match human hormones and carry standardized, tested doses 3Ref 3Stuenkel CA, et al. (Endocrine Society) (2015).Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations.4Ref 4MedlinePlus (National Library of Medicine) (2026).Hormone Replacement Therapy.Patient-facing NIH overview describing the FDA-approved forms of hormone therapy, including estradiol patches and gels and oral progesterone, with standardized labeled doses..
Because they are regulated, each package lists its exact hormone content and its risks, and the dose in one patch matches the next 4Ref 4MedlinePlus (National Library of Medicine) (2026).Hormone Replacement Therapy.Patient-facing NIH overview describing the FDA-approved forms of hormone therapy, including estradiol patches and gels and oral progesterone, with standardized labeled doses.. An Endocrine Society guideline notes that these approved body-identical options meet the needs of most women seeking hormone therapy 3Ref 3Stuenkel CA, et al. (Endocrine Society) (2015).Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations.. In other words, the supposed advantage of compounded bioidenticals, matching the body's hormones, is already available in a tested form.
What is different about compounded bioidenticals?
Custom-compounded preparations are mixed by a pharmacy to a prescriber's recipe and are not reviewed or approved by the FDA 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. Because each batch is made individually, the dose can vary from one refill to the next, and the products are not required to carry the standardized safety warnings that approved therapies include 5Ref 5National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).NICE menopause guideline stating that compounded bioidentical hormones lack good evidence for efficacy and safety and are not recommended..
According to NICE guidance, compounded bioidentical hormones lack good evidence for their efficacy and safety and are not recommended 5Ref 5National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).NICE menopause guideline stating that compounded bioidentical hormones lack good evidence for efficacy and safety and are not recommended.. Claims that saliva or blood tests can custom-tune a person's hormone blend are not validated, and the Menopause Society advises against using them to guide dosing 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. Compounded products can still carry the same class risks, including effects on the breast and on clotting, but without the same oversight 2Ref 2American College of Obstetricians and Gynecologists (2014).ACOG Practice Bulletin No. 141: management of menopausal symptoms.ACOG guidance that compounded bioidentical preparations are not recommended over FDA-approved therapy and can carry the same class risks without standardized oversight..
Are they actually safer?
No major menopause or endocrine society considers compounded bioidenticals safer than FDA-approved therapy 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.3Ref 3Stuenkel CA, et al. (Endocrine Society) (2015).Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations.. The same benefit-risk framework applies to any systemic estrogen: for healthy women under 60 or within 10 years of menopause, benefits generally outweigh risks, and that window is defined by good data on approved products, not compounded ones 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause..
Women who reach menopause early, before the typical range of ages 45 to 55, often use hormone therapy until around that age, and regulated body-identical options serve them well too 6Ref 6World Health Organization (2024).Menopause (fact sheet).WHO fact sheet that natural menopause usually occurs between ages 45 and 55, supporting the life-stage framing for early menopause and duration of therapy.. The combined-therapy breast-cancer signal emerges mainly after about 3 to 5 years of use and is a property of the hormones, not of the bioidentical label 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. Comparing regulated hormone replacement therapy with a clinician keeps the decision grounded.
When bioidentical HRT questions need a clinician
A menopause-focused clinician can match you to a regulated body-identical option and explain its real risks and benefits 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.. They can also review why a compounded product was suggested and whether an approved equivalent, often the same molecule, would do the same job with tested dosing 3Ref 3Stuenkel CA, et al. (Endocrine Society) (2015).Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations.. If cost or an ingredient allergy is the reason compounding came up, a clinician can usually name an approved alternative or a workaround 3Ref 3Stuenkel CA, et al. (Endocrine Society) (2015).Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations..
For symptoms like hot flashes or vaginal dryness, or broader menopause symptoms and perimenopause changes, the right form depends on your history. Gale can help you organize that history beforehand.
Common questions
Related
Menopause & midlife
Compounded Hormones: Why Insurance Says NoMenopause & midlife
HRT Explained: What Hormone Therapy Actually DoesMenopause & midlife
HRT and Weight: What Trials Actually Found
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to double-check a hormone product
- —A product described as bioidentical but with no package insert, lot number, or listed dose is a reason to seek clinician review before use.
- —New or unexplained vaginal bleeding after menopause on any hormone product is a reason to arrange prompt evaluation.
- —A new breast lump or nipple change is a reason to book an evaluation, whatever the product's label.
- —Sudden leg swelling, calf pain, or shortness of breath warrants urgent medical care to rule out a blood clot.
This article is general health education, not medical advice. Whether an FDA-approved or any other hormone product suits you depends on your history and should be decided with a gynecologist or menopause clinician.
References
- 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓The 2022 Menopause Society position statement that the term bioidentical describes structure not safety, that saliva or blood testing to customize dosing is not validated, and that benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.
- 2.American College of Obstetricians and Gynecologists (2014). ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstetrics & Gynecology. doi:10.1097/01.AOG.0000441353.20693.78 ✓ACOG guidance that compounded bioidentical preparations are not recommended over FDA-approved therapy and can carry the same class risks without standardized oversight.
- 3.Stuenkel CA, et al. (Endocrine Society) (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2015-2236 ✓Endocrine Society clinical practice guideline that FDA-approved body-identical options, including transdermal estradiol and micronized progesterone, meet the needs of most women and are preferred over compounded preparations.
- 4.MedlinePlus (National Library of Medicine) (2026). Hormone Replacement Therapy. MedlinePlus, U.S. National Library of Medicine (NIH). link ✓Patient-facing NIH overview describing the FDA-approved forms of hormone therapy, including estradiol patches and gels and oral progesterone, with standardized labeled doses.
- 5.National Institute for Health and Care Excellence (2026). Menopause: identification and management (NG23). National Institute for Health and Care Excellence (NICE). link ✓NICE menopause guideline stating that compounded bioidentical hormones lack good evidence for efficacy and safety and are not recommended.
- 6.World Health Organization (2024). Menopause (fact sheet). World Health Organization (WHO). link ✓WHO fact sheet that natural menopause usually occurs between ages 45 and 55, supporting the life-stage framing for early menopause and duration of therapy.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy